Common Contracts
8 similar Employment Agreement contracts by Proteostasis Therapeutics, Inc.
CONFIDENTIALEmployment Agreement • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
CONFIDENTIALEmployment Agreement • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
CONFIDENTIALEmployment Agreement • March 14th, 2018 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
October 21, 2016 Re:Amended and Restated Employment Agreement Dear Po-Shun:Employment Agreement • November 10th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
October 21, 2016 Re:Amended and Restated Employment Agreement Dear Meenu:Employment Agreement • November 10th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
The Board of Directors has recently reviewed the terms and conditions of your employment and is pleased to provide this amended and restated letter agreement (the “Agreement”) modifying the terms of your employment in your continuing role as President and Chief Executive Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”). This Agreement amends, restates, and supersedes in its entirety the letter agreement dated April 4, 2014 between you and the Company (the “Offer Letter Agreement”) and the letter agreement dated March 10, 2016. This Agreement is effective as of the date hereof.
Re: Employment AgreementEmployment Agreement • August 8th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement (the “Agreement”) outlines the terms of your employment in your role as Chief Financial Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”).
CONFIDENTIAL March 11, 2016 Po-Shun Lee, M.D.Employment Agreement • March 16th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Re: Employment AgreementEmployment Agreement • March 16th, 2016 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
The Board of Directors has recently reviewed the terms and conditions of your employment and is pleased to provide this letter agreement (the “Agreement”) modifying the terms of your employment in your continuing role as President and Chief Executive Officer of Proteostasis Therapeutics, Inc. (“Proteostasis” or the “Company”). This Agreement amends, restates, and supersedes in its entirety the letter agreement dated April 4, 2014 between you and the Company (the “Offer Letter Agreement”). This Agreement is effective as of the date hereof.
